Taragenyx Ltd.

Industry

  • Digital Health
    • Disease Management
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Biotechnology
See more in Biomedtracker

Latest on Taragenyx Ltd.

Scrip

Start-Up Quarterly Statistics, Q1 2013

 
• By Deanna Kamienski

Financings In the first quarter of 2013, start-up companies generated a total of $398.7 million across all industries, which was a 59% drop from the previous quarter’s $670.3 million. ( See Exhibit 1.

Scrip

Recent Financings Of Private Companies, May 2013

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS Asuragen Inc. Series D round brings $15mm to Asuragen Asuragen Inc. (mRNA- and miRNA-based molecular diagnostics for cancer and genetic diseases) raised $15mm from 15 undi

Scrip

Emergings In Brief, April 2013

 
• By Nancy Dvorin

Neurotrack Technologies Inc. 4200 Grove Avenue Richmond, VA 23221 Phone: (404) 402-9863 Email: elli@neurotrack.com Web Site: www.neurotrack.com Management: Elli Kaplan, CEO Company Launched: October

Medtech Insight

Medical Device Deals Update, April 2013

Elsevier’s Strategic Transactions